In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.

Source

Forbes

Read full article at Forbes

Opens original article in a new tab

Platinum forecast and tracker: How will platinum perform in 2026?

about 1 hour agoRead more →

EconomyDaily Composite

Yahoo Finance

Up 981%, Is Western Digital Stock Still a Buy?

about 1 hour agoRead more →

EconomyDaily Composite

Yahoo Finance

This AI Stock Took Sell-Off In Stride. It's At A New Buy Point.

about 1 hour agoRead more →

Bloomberg Markets

Mercuria’s First-Half Profit Jumped 88% on Commodity Shocks

Mercuria Energy Group enjoyed an 88% jump in first-half profit, putting it on track for one of its best-ever annual results as the Hormuz crisis creates huge opportunities for commodity traders.

about 1 hour agoRead more →

Related Economy Stories

Platinum forecast and tracker: How will platinum perform in 2026?

Up 981%, Is Western Digital Stock Still a Buy?

This AI Stock Took Sell-Off In Stride. It's At A New Buy Point.

Mercuria’s First-Half Profit Jumped 88% on Commodity Shocks